Skip to the reference entry
Notice: This is NOT an official government website. We are not affiliated with any government agency.

Reference entry

Semaglutide

Also listed as Wegovy

Read the scope, examine the source, and keep your own question alongside the evidence.

Status labels apply within the product, route, and use described below. Read the limitations alongside that scope.

Scoped product status
Approved product
Evidence label
Randomized evidence

Status as of

Reference fields

Sources for these fields

Product and use
Wegovy injection: weight management in eligible adults.
Route context
This entry covers subcutaneous Wegovy injection.
Mechanism
Activates the GLP-1 receptor.
Evidence
Randomized trials.
Limitations
Check other products separately.
Safety
Severe or persistent gastrointestinal symptoms: contact a clinician.

Sources

These references support the fields as a group. Follow a source to check the original wording and its scope.

  1. WEGOVYNLM · Checked
  2. Wegovy approvalFDA · Checked

Continue reading

Reading topics: Metabolism. These organize the library and do not describe recommended uses.

Educational reference information. No clinician review is claimed. This entry does not provide personal medical advice.